Blog

High-cost therapeutics
Funding challenges of super-high-cost therapeutics

Since the completion of the human genome project in 2003, researchers at the 1000 Genomes Project have sequenced over 2500 human genomes from 26 groups of people around the world; the genome of a human from around 430,000 years ago has been sequenced; and the UK plans to sequence 100,000 human genomes from NHS patients. […]

Real-world data: Social media beyond pharmacovigilance

While there are challenges to be overcome, the opportunities of social media to generate useful insights that could improve drug development, disease diagnosis and treatment, are enormous and are only likely to grow.

Drug launch excellence: Begin the value story early

Starting the market access plans as early as possible, even during the early stages of development, will improve a company’s chance of success at drug launch.